26 05, 2019 Libor Stanek et al., Expression level of NRP1 and SMAD2 in correlation to mutational status of RAS (BRAF) in pancreatic cancer. Diatech Pharmacogenetics2020-01-22T12:19:35+01:00 Leggi di più